# Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma

> **NCT07456605** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Myeloma Refractory
- Multiple Myeloma in Relapse

## Interventions

- **DRUG:** Liposomal Curcumin (LipoCurc)

## Key facts

- **NCT ID:** NCT07456605
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2028-03-02
- **Final completion:** 2028-03-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07456605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07456605, "Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07456605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*